155 related articles for article (PubMed ID: 31315482)
1. Correlation between adverse events after drug treatment and the
Luo H; Qin G; Yao C
J Int Med Res; 2019 Aug; 47(8):3522-3533. PubMed ID: 31315482
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of oral metronomic vinorelbine in advanced non-small cell lung cancer: correlations with pharmacokinetics and MDR1 polymorphisms.
Gusella M; Pasini F; Caruso D; Barile C; Modena Y; Fraccon AP; Bertolaso L; Menon D; Crepaldi G; Bononi A; Spezzano R; Telatin GA; Corona G; Padrini R
Cancer Chemother Pharmacol; 2019 Mar; 83(3):493-500. PubMed ID: 30542768
[TBL] [Abstract][Full Text] [Related]
3. Association between MDR1 C3435T polymorphism and refractory epilepsy in the Chinese population: a systematic review and meta-analysis.
Cheng JW; Zhang LJ; Hou YQ; Zhao Q; Zhang XJ; Chen XF; Bai Y
Epilepsy Behav; 2014 Jul; 36():173-9. PubMed ID: 24953225
[TBL] [Abstract][Full Text] [Related]
4. Association between MDR1 C3435T polymorphism and colorectal cancer risk: A meta-analysis.
Jin SS; Song WJ
Medicine (Baltimore); 2017 Dec; 96(51):e9428. PubMed ID: 29390571
[TBL] [Abstract][Full Text] [Related]
5. Genetic Association of Curative and Adverse Reactions to Tyrosine Kinase Inhibitors in Chinese advanced Non-Small Cell Lung Cancer patients.
Ruan Y; Jiang J; Guo L; Li Y; Huang H; Shen L; Luan M; Li M; Du H; Ma C; He L; Zhang X; Qin S
Sci Rep; 2016 Mar; 6():23368. PubMed ID: 26988277
[TBL] [Abstract][Full Text] [Related]
6. Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients.
Qian CY; Zheng Y; Wang Y; Chen J; Liu JY; Zhou HH; Yin JY; Liu ZQ
Chin J Cancer; 2016 Sep; 35(1):85. PubMed ID: 27590272
[TBL] [Abstract][Full Text] [Related]
7. Population Pharmacokinetics and Adverse Events of Erlotinib in Japanese Patients with Non-small-cell Lung Cancer: Impact of Genetic Polymorphisms in Metabolizing Enzymes and Transporters.
Endo-Tsukude C; Sasaki JI; Saeki S; Iwamoto N; Inaba M; Ushijima S; Kishi H; Fujii S; Semba H; Kashiwabara K; Tsubata Y; Hayashi M; Kai Y; Saito H; Isobe T; Kohrogi H; Hamada A
Biol Pharm Bull; 2018; 41(1):47-56. PubMed ID: 29311482
[TBL] [Abstract][Full Text] [Related]
8. Significance of MDR1 gene C3435T polymorphism in predicting childhood refractory epilepsy.
Lv RJ; Shao XQ; Cui T; Wang Q
Epilepsy Res; 2017 May; 132():21-28. PubMed ID: 28284049
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic profiles of significant adverse events with crizotinib in Japanese patients with ABCB1 polymorphism.
Fujiwara Y; Hamada A; Mizugaki H; Aikawa H; Hata T; Horinouchi H; Kanda S; Goto Y; Itahashi K; Nokihara H; Yamamoto N; Ohe Y
Cancer Sci; 2016 Aug; 107(8):1117-23. PubMed ID: 27270784
[TBL] [Abstract][Full Text] [Related]
10. Effects of pharmacokinetics-related genetic polymorphisms on the side effect profile of afatinib in patients with non-small cell lung cancer.
Hayashi H; Iihara H; Hirose C; Fukuda Y; Kitahora M; Kaito D; Yanase K; Endo J; Ohno Y; Suzuki A; Sugiyama T
Lung Cancer; 2019 Aug; 134():1-6. PubMed ID: 31319966
[TBL] [Abstract][Full Text] [Related]
11. Associations of polymorphisms in DNA repair genes and MDR1 gene with chemotherapy response and survival of non-small cell lung cancer.
Du Y; Su T; Zhao L; Tan X; Chang W; Zhang H; Cao G
PLoS One; 2014; 9(6):e99843. PubMed ID: 24933103
[TBL] [Abstract][Full Text] [Related]
12. Inherited variation in the ATP-binding cassette transporter ABCB1 and survival after chemotherapy for stage III-IV lung cancer.
Weissfeld JL; Diergaarde B; Nukui T; Buch S; Pennathur A; Socinski MA; Siegfried JM; Romkes M
J Thorac Oncol; 2014 Sep; 9(9):1264-71. PubMed ID: 25122423
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of ERCC1 C118T/C8092A and MDR1 C3435T predict outcome of platinum-based chemotherapies in advanced non-small cell lung cancer: a meta-analysis.
Wei HB; Lu XS; Shang LH; Xu G; Hu J; Che DH; Liu F; Wu Y; Zhang GM; Yu Y
Arch Med Res; 2011 Jul; 42(5):412-20. PubMed ID: 21827803
[TBL] [Abstract][Full Text] [Related]
14. MDR1 C3435T polymorphism has no influence on developing Helicobacter pylori infection-related gastric cancer and peptic ulcer in Japanese.
Sugimoto M; Furuta T; Shirai N; Kodaira C; Nishino M; Yamade M; Ikuma M; Sugimura H; Ishizaki T; Hishida A
Life Sci; 2008 Aug; 83(7-8):301-4. PubMed ID: 18644389
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of the adenosine triphosphate-binding cassette transporters (ABCG2, ABCB1) and gefitinib toxicity.
Tamura M; Kondo M; Horio M; Ando M; Saito H; Yamamoto M; Horio Y; Hasegawa Y
Nagoya J Med Sci; 2012 Feb; 74(1-2):133-40. PubMed ID: 22515119
[TBL] [Abstract][Full Text] [Related]
16. A phase II trial of triapine (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503.
Traynor AM; Lee JW; Bayer GK; Tate JM; Thomas SP; Mazurczak M; Graham DL; Kolesar JM; Schiller JH
Invest New Drugs; 2010 Feb; 28(1):91-7. PubMed ID: 19238328
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism in
Zhang YX; Ma Y; Zhang H; Zhang WP; Yang XY
Int J Clin Pharmacol Ther; 2020 May; 58(5):254-260. PubMed ID: 32053102
[TBL] [Abstract][Full Text] [Related]
18. Association of XPD polymorphisms with severe toxicity in non-small cell lung cancer patients in a Chinese population.
Wu W; Zhang W; Qiao R; Chen D; Wang H; Wang Y; Zhang S; Gao G; Gu A; Shen J; Qian J; Fan W; Jin L; Han B; Lu D
Clin Cancer Res; 2009 Jun; 15(11):3889-95. PubMed ID: 19458053
[TBL] [Abstract][Full Text] [Related]
19. MDR1 C3435T polymorphism and interaction with environmental factors in risk of Parkinson's disease: a case-control study in Japan.
Kiyohara C; Miyake Y; Koyanagi M; Fujimoto T; Shirasawa S; Tanaka K; Fukushima W; Sasaki S; Tsuboi Y; Yamada T; Oeda T; Shimada H; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M;
Drug Metab Pharmacokinet; 2013; 28(2):138-43. PubMed ID: 22971641
[TBL] [Abstract][Full Text] [Related]
20. MDR1 gene polymorphisms and imatinib response in chronic myeloid leukemia: a meta-analysis.
Zu B; Li Y; Wang X; He D; Huang Z; Feng W
Pharmacogenomics; 2014 Apr; 15(5):667-77. PubMed ID: 24798723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]